Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Lawmakers bet millions on pharma stocks as Trump targets industry Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

The first phase of Fujifilm Biotechnologies’ $3.2-billion large-scale cell culture biopharmaceutical manufacturing plant in North Carolina is scheduled to begin operating this year.

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment o ...

NBA Commissioner Adam Silver addresses why there are no NBA Finals logos on the court, last seen in 2014.

On June 20, Madrigal Pharmaceuticals moved closer to introducing the first treatment for metabolic dysfunction-associated steatohepatitis/MASH in Europe.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

The impact of pharmaceutical roundtripping on the trade balance is both too big to continue and too big to ignore. Time for some real changes.

Recombinant Factor C endotoxin detection technology is crucial in pharmaceutical manufacturing for enhancing product safety and supporting sustainability goals.

Elite Pharmaceuticals, Inc. (OTCQB:ELTP) Q4 2025 Earnings Conference Call July 1, 2025 11:30 AM ETCompany ParticipantsCarter J.

October Pharma Annual stock financials by MarketWatch. View the latest OCPH financial statements, income statements and financial ratios.